These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3110886)

  • 1. Effect of encainide on in vivo drug metabolism in the rat.
    Svensson CK; Knowlton PW
    Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):285-8. PubMed ID: 3110886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effect of propafenone on in vivo drug metabolism in the rat.
    Chong MT; Svensson CK
    Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):147-56. PubMed ID: 3423421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of encainide versus diltiazem on the oxidative metabolic pathways of antipyrine.
    Bottorff MB; Lalonde RL; Kazierad DJ; Hoon TJ; Tsiu SJ; Mirvis DM
    Pharmacotherapy; 1989; 9(5):315-21. PubMed ID: 2510135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic activity of the O-demethyl metabolite of encainide.
    Roden DM; Duff HJ; Altenbern D; Woosley RL
    J Pharmacol Exp Ther; 1982 Jun; 221(3):552-7. PubMed ID: 6806461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antiarrhythmic actions of encainide and its major metabolites.
    Gomoll AW; Byrne JE; Mayol RF
    Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):277-97. PubMed ID: 3092755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and quantitative comparison of the cardiac effects of encainide and its three major metabolites in the dog.
    Davy JM; Dorian P; Kantelip JP; Harrison DC; Kates RE
    J Pharmacol Exp Ther; 1986 Jun; 237(3):907-11. PubMed ID: 3086540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of genetic polymorphism on the metabolism and disposition of encainide in man.
    Wang T; Roden DM; Wolfenden HT; Woosley RL; Wood AJ; Wilkinson GR
    J Pharmacol Exp Ther; 1984 Mar; 228(3):605-11. PubMed ID: 6423808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent pharmacokinetics of antipyrine in the rat.
    Pollack GM; Li RC; Shen DD
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):69-81. PubMed ID: 6729251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of encainide and metabolites (MJ14030 and MJ9444) on canine cardiac Purkinje and ventricular fibers.
    Elharrar V; Zipes DP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):440-7. PubMed ID: 6799644
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of encainide on the determinants of cardiac excitability in sheep Purkinje fibers.
    Arnsdorf MF; Schmidt GA; Sawicki GJ
    J Pharmacol Exp Ther; 1985 Jan; 232(1):40-8. PubMed ID: 3917508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of drug effects on spontaneous and induced ventricular arrhythmias in a 24-h canine infarction model.
    Gomoll AW
    Arzneimittelforschung; 1987 Jul; 37(7):787-94. PubMed ID: 3118889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of encainide and its two major metabolites on cardiac conduction.
    Dresel PE
    J Pharmacol Exp Ther; 1984 Jan; 228(1):180-6. PubMed ID: 6420542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of digoxin-encainide interactions using an animal model.
    Weinhouse E; Tribble J; Jarenwattananon M; Nudel DB
    Clin Cardiol; 1988 Jul; 11(7):474-80. PubMed ID: 3138054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
    Cassagneau B; Miquel JP; Puel JP; Mordant B; Kher A; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New anti-arrhythmia drugs].
    Vidal Garate J; Romero-Ayala LC; Cárdenas Loaeza M
    Arch Inst Cardiol Mex; 1983; 53(2):159-78. PubMed ID: 6411015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of anti-arrhythmia agent, gallanilide, on hepatic drug metabolizing enzymes in rats].
    Li D; Xu H; Yang J; Huang Y; Zhu H
    Yao Xue Xue Bao; 1984 Apr; 19(4):300-2. PubMed ID: 6496106
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of encainide on myocardial contractility of cat papillary muscle.
    Brutsaert DL
    Eur J Pharmacol; 1981 Dec; 76(2-3):267-9. PubMed ID: 6800830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic modeling of antiarrhythmic drug effects--application to 3-methoxy-O-demethyl encainide.
    Dorian P; Davy JM; Kates RE
    J Cardiovasc Pharmacol; 1986; 8(6):1217-22. PubMed ID: 2434749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hypoxia and pregnancy on antipyrine metabolism in isolated perfused rat livers.
    Brouwer KL; Vore M
    J Pharmacol Exp Ther; 1985 Sep; 234(3):584-9. PubMed ID: 4032283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between antipyrine kinetics and the change in the seromucoid content of rat plasma under the influence of the immunomodulator levamisole].
    Kupchikov VV; Bender KI; Lutsevich AN; Gangnus VS
    Farmakol Toksikol; 1990; 53(5):55-8. PubMed ID: 2253753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.